Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Home » Rise in hospitalisations for common childhood respiratory virus
A summary of research published in ERJ Open Research
Respiratory syncytial virus (RSV) affects most babies by the time they are two years old. For most, the symptoms are like a common cold. During the pandemic, many countries placed restrictions on children going to school and spending time with friends. As these restrictions lift, there has been a rise in the number of RSV infections that need a hospital visit.
This new study aims to look at the global trends for RSV to help policymakers plan for the future.
The study looked at all research related to RSV published between January 2009 and May 2021. It collected the data together to help spot patterns in the numbers during the pandemic and as restrictions have been lifted.
The findings revealed:
This study groups together reports on hospital visits for RSV to look at what is happening with this virus across the world. As restrictions ease and children are interacting again, there is likely to be a continued increase in the number of hospital visits for RSV. The numbers could also peak at different times of the year, rather than just winter. These findings are important to help prepare healthcare systems that may be struggling after the COVID-19 pandemic.
Read the original research paper:
Title: Respiratory Syncytial Virus (RSV) associated hospitalisation in children age ≤5 years: A scoping review of literature from 2009-2021
https://openres.ersjournals.com/content/early/2022/03/24/23120541.00593-2021
Sign up to get the latest information and research on lung conditions, hear about our upcoming events and campaigns, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79